Abu Dhabi Investment Authority - Net Worth and Insider Trading
Abu Dhabi Investment Authority Net Worth
The estimated net worth of Abu Dhabi Investment Authority is at least $1.5 Billion dollars as of 2024-04-29. Abu Dhabi Investment Authority is the 10% Owner of Hyatt Hotels Corp and owns about 4,763,005 shares of Hyatt Hotels Corp (H) stock worth over $721 Million. Abu Dhabi Investment Authority is the Member of 10% owner group of Brookfield Property REIT Inc and owns about 38,478,639 shares of Brookfield Property REIT Inc (BPYU) stock worth over $713 Million. Abu Dhabi Investment Authority is also the of Vir Biotechnology Inc and owns about 3,666,666 shares of Vir Biotechnology Inc (VIR) stock worth over $30 Million. Besides these, Abu Dhabi Investment Authority also holds Foghorn Therapeutics Inc (FHTX) . Details can be seen in Abu Dhabi Investment Authority's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Abu Dhabi Investment Authority has not made any transactions after 2020-10-27 and currently still holds the listed stock(s).
Transaction Summary of Abu Dhabi Investment Authority
Abu Dhabi Investment Authority Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Abu Dhabi Investment Authority owns 5 companies in total, including Foghorn Therapeutics Inc (FHTX) , Vir Biotechnology Inc (VIR) , and Brookfield Property REIT Inc (BPYU) among others .
Click here to see the complete history of Abu Dhabi Investment Authority’s form 4 insider trades.
Insider Ownership Summary of Abu Dhabi Investment Authority
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-27 | 10 percent owner |
| VIR | Vir Biotechnology Inc | 2019-10-16 | 10 percent owner |
| BPYU | Brookfield Property REIT Inc | 2016-04-08 | other: Member of 10% owner group |
| CFMS | Conformis Inc | 2015-06-30 | director & 10 percent owner |
| H | Hyatt Hotels Corp | 2010-08-30 | 10 percent owner |
Abu Dhabi Investment Authority Latest Holdings Summary
Abu Dhabi Investment Authority currently owns a total of 4 stocks. Among these stocks, Abu Dhabi Investment Authority owns 4,763,005 shares of Hyatt Hotels Corp (H) as of August 30, 2010, with a value of $721 Million and a weighting of 49.02%. Abu Dhabi Investment Authority owns 38,478,639 shares of Brookfield Property REIT Inc (BPYU) as of April 8, 2016, with a value of $713 Million and a weighting of 48.47%. Abu Dhabi Investment Authority also owns 3,666,666 shares of Vir Biotechnology Inc (VIR) as of October 16, 2019, with a value of $30 Million and a weighting of 2.05%. The other 1 stocks Foghorn Therapeutics Inc (FHTX) have a combined weighting of 0.46% among all his current holdings.
Latest Holdings of Abu Dhabi Investment Authority
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| H | Hyatt Hotels Corp | 2010-08-30 | 4,763,005 | 151.32 | 720,737,917 |
| BPYU | Brookfield Property REIT Inc | 2016-04-08 | 38,478,639 | 18.52 | 712,624,394 |
| VIR | Vir Biotechnology Inc | 2019-10-16 | 3,666,666 | 8.23 | 30,176,661 |
| FHTX | Foghorn Therapeutics Inc | 2020-10-27 | 1,231,081 | 5.49 | 6,758,635 |
Holding Weightings of Abu Dhabi Investment Authority
Abu Dhabi Investment Authority Form 4 Trading Tracker
According to the SEC Form 4 filings, Abu Dhabi Investment Authority has made a total of 0 transactions in Hyatt Hotels Corp (H) over the past 5 years. The most-recent trade in Hyatt Hotels Corp is the sale of 4,781,500 shares on August 30, 2010, which brought Abu Dhabi Investment Authority around $199 Million.
According to the SEC Form 4 filings, Abu Dhabi Investment Authority has made a total of 0 transactions in Brookfield Property REIT Inc (BPYU) over the past 5 years. The most-recent trade in Brookfield Property REIT Inc is the sale of 936 shares on April 8, 2016, which brought Abu Dhabi Investment Authority around $26,966.
According to the SEC Form 4 filings, Abu Dhabi Investment Authority has made a total of 1 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vir Biotechnology Inc is the acquisition of 1,000,000 shares on October 16, 2019, which cost Abu Dhabi Investment Authority around $20 Million.
More details on Abu Dhabi Investment Authority's insider transactions can be found in the Insider Trading History of Abu Dhabi Investment Authority table.Insider Trading History of Abu Dhabi Investment Authority
- 1
Abu Dhabi Investment Authority Trading Performance
GuruFocus tracks the stock performance after each of Abu Dhabi Investment Authority's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Abu Dhabi Investment Authority is 12.48%. GuruFocus also compares Abu Dhabi Investment Authority's trading performance to market benchmark return within the same time period. The performance of stocks bought by Abu Dhabi Investment Authority within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Abu Dhabi Investment Authority's insider trading performs compared to the benchmark.
Performance of Abu Dhabi Investment Authority
Average Return
72.14%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.46 | 12.48 | 35.03 | 72.14 | 17.12 | -14.42 |
| Relative Return to S&P 500(%) | 3.62 | 1.7 | 26.47 | 46.78 | 2.99 | -20.88 |
Abu Dhabi Investment Authority Ownership Network
Ownership Network List of Abu Dhabi Investment Authority
Ownership Network Relation of Abu Dhabi Investment Authority
Abu Dhabi Investment Authority Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Abu Dhabi Investment Authority is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief Strategy/Bus Ops Officer Fanny Cavalie , Chief Medical Officer Alfonso Quintas Cardama , and Chief Medical Officer Samuel Agresta .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Abu Dhabi Investment Authority made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 11,000 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 11,000 shares. During the past 18 months, 322,297 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,297 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Abu Dhabi Investment Authority Mailing Address
Above is the net worth, insider trading, and ownership report for Abu Dhabi Investment Authority. You might contact Abu Dhabi Investment Authority via mailing address: 211 Corniche Street, Po Box 3600, Abu Dhabi C0 0000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
